Clinical trial reportLeukemiaPublished
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis
14 of 32 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- Counties
- Mercer County, Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Leukemia
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Prognosis; Survival Rate; Follow-Up Studies; Aged; Middle Aged; Female; Male
- PubMed ID
- 42637879
- PubMed Central ID
- PMC13713557
- Open access
- Yes, open
- Added to directory
- Source checked